ForteBio Revenue and Competitors

Location

$42.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ForteBio's estimated annual revenue is currently $5.7M per year.(i)
  • ForteBio received $25.0M in venture funding in September 2008.
  • ForteBio's estimated revenue per employee is $77,500
  • ForteBio's total funding is $42.3M.

Employee Data

  • ForteBio has 74 Employees.(i)
  • ForteBio grew their employee count by -5% last year.

ForteBio's People

NameTitleEmail/Phone
1
Quality Control AssociateReveal Email/Phone
2
Principal Product Development EngineerReveal Email/Phone
3
Senior Mechanical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M102-3%$38.1MN/A
Add Company

What Is ForteBio?

EMPOWER THE DEVELOPMENT OF VITAL BIOLOGICS THAT CURE DISEASES. ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer products that span multiple technology vectors including analytical instrumentation and software, clone picking and imaging, and, automation and customization engineering solutions. We develop and supply products for biomolecular analysis, including real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration. Our solutions for antibody discovery and cell line development provide dedicated, scalable, and easy-to-use products for establishing clonal populations. The systems feature a selection of options and models to address your specific research including multiple imaging modes, biology-specific pins, fluidics, and environmental control. These solutions combine intelligent imaging with analysis and automation to increase throughput, consistency, and provide image-based documentation.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

$42.3M

Total Funding

74

Number of Employees

$5.7M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ForteBio News

2022-04-20 - An ACE2-blocking antibody confers broad neutralization and ...

87G7 (21 nM) was loaded onto Protein A biosensors (ForteBio) for 10 min. Antigen binding was performed by incubating the biosensor with...

2022-04-20 - Profacgen Updated Its Bio-Layer Interferometry Service ...

... a label-free detection system for molecular interaction analysis based on the principle of optical interference developed by ForteBio.

2022-04-19 - Label-free Array Systems Market Size, Outlook And Forecast ...

Agilent Technologies, Attana, Biacore, ForteBio, Perkin Elmer, F. Hoffman La Roche. This comprehensive Label-free Array Systems Market...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M747%N/A
#2
$22M74-3%N/A
#3
$9.3M744%$16.3M
#4
$14.9M749%N/A
#5
$19.4M759%N/A

ForteBio Funding

DateAmountRoundLead InvestorsReference
2005-10-27$17.3MBVertical GroupArticle
2008-09-24$25.0MCOrbiMed AdvisorsArticle